SIRFLOX

Welcome to the Brand page for “SIRFLOX”, which is offered here for In the statement, lines 14 and 17, after deliver material, for medical and veterinary purposes should be inserted.;pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, for the treatment of cancer; capsules and particles for medical and pharmaceutical purposes, for the treatment of cancer; chemical preparations for medical and pharmaceutical purposes, for the treatment of cancer; chemical preparations for veterinary purposes, for the treatment of cancer; drugs for medical purposes for the treatment of cancer; microcapsules for medical purposes, for the treatment of cancer; microscopic particles containing radioactive material for medical therapeutic use; microcapsules containing pharmaceutical, veterinary or medical preparations, for the treatment of cancer; microcapsules and microparticles for the treatment of cancer adapted to selectively deliver material * for medical and veterinary purposes *, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ; microscopic particles and microcapsules for the treatment of cancer and other diseased cells; microscopic particles for the treatment of cancer adapted to selectively deliver material * for medical and veterinary purposes *, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ;color is not claimed as a feature of the mark.;medical research; scientific research for medical purposes; research and development of medical and veterinary products and for medical and veterinary purposes, including pharmaceuticals, microcapsules, microparticles, radioactive materials, chemical agents and preparations, cancer treatments and treatments for diseased cells; research relating to molecular sciences, pharmaceuticals, drugs, chemicals and biotechnology;.

Its status is currently believed to be active. Its class is unavailable. “SIRFLOX” is believed to be currently owned by “Sirtex Technology Pty Ltd.”

Owner:
SIRTEX TECHNOLOGY PTY LTD.
Owner Details
Description:
In the Statement, lines 14 and 17, after DELIVER MATERIAL, for medical and veterinary purposes should be inserted.;Pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, for the treatment of cancer; capsules and particles for medical and pharmaceutical purposes, for the treatment of cancer; chemical preparations for medical and pharmaceutical purposes, for the treatment of cancer; chemical preparations for veterinary purposes, for the treatment of cancer; drugs for medical purposes for the treatment of cancer; microcapsules for medical purposes, for the treatment of cancer; microscopic particles containing radioactive material for medical therapeutic use; microcapsules containing pharmaceutical, veterinary or medical preparations, for the treatment of cancer; microcapsules and microparticles for the treatment of cancer adapted to selectively deliver material * for medical and veterinary purposes *, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ; microscopic particles and microcapsules for the treatment of cancer and other diseased cells; microscopic particles for the treatment of cancer adapted to selectively deliver material * for medical and veterinary purposes *, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ;Color is not claimed as a feature of the mark.;Medical research; scientific research for medical purposes; research and development of medical and veterinary products and for medical and veterinary purposes, including pharmaceuticals, microcapsules, microparticles, radioactive materials, chemical agents and preparations, cancer treatments and treatments for diseased cells; research relating to molecular sciences, pharmaceuticals, drugs, chemicals and biotechnology;
Categories: STATEMENT